Guangdong’s OptoMedic Secures Over $27.8 Million in Pre-IPO Financing for Endoscopy Innovations
OptoMedic Technologies, Inc., a leading endoscopy specialist based in Guangdong, has reportedly raised upwards of...
OptoMedic Technologies, Inc., a leading endoscopy specialist based in Guangdong, has reportedly raised upwards of...
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced receiving market approval for its...
Ningbo-based structural heart disease intervention device manufacturer, Jenscare Scientific Co., Ltd (HKG: 9877), has announced...
China-based Broncus Medical Inc., (HKG: 2216), a provider of precision intervention solutions focused on lung...
Singapore-based Genesis MedTech has announced that it has received market approval in China for its...
Peijia Medical Ltd (HKG: 9996), a leading Chinese firm in the neurointerventional field, has announced...
US-based Zap Surgical Systems Inc. has announced that it has received market approval in China...
Helio Genomics has announced that its ‘sister company’ Laboratory for Advanced Medicine & Health Group...
China-based Bio-heart Biological Technology Co., Ltd. (HKG: 2185) and its holding subsidiary Angiocare have announced...
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced that its in-house developed Dragonfly...
China-based Sino Medical Sciences Technology Inc., (SHA: 688108) has announced that it has received market...
Ruitai Bio’s Epicon A, a scleral lens product from Australia, has been approved by the...
The National Medical Products Administration (NMPA) has granted marketing approval to Suzhou MicroPort Joint Medical...
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai...
The National Medical Products Administration (NMPA) has granted marketing approval to Shanghai Magic Medicine’s multimodal...
The National Medical Products Administration (NMPA) has issued market approval for the implantable left ventricular...
China-based Zai Lab Ltd (ZLAB) (NASDAQ: ZLAB; HKG: 9688) and its partner Novocure Ltd (NASDAQ:...
The National Medical Products Administration (NMPA) has granted marketing approval for the “coronary artery interventional...
The National Medical Products Administration (NMPA) in China has issued market approval to Lanzhou Kejin...
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced that it has received marketing...